1. Home
  2. CARM vs SSKN Comparison

CARM vs SSKN Comparison

Compare CARM & SSKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CARM
  • SSKN
  • Stock Information
  • Founded
  • CARM 2016
  • SSKN 1989
  • Country
  • CARM United States
  • SSKN United States
  • Employees
  • CARM N/A
  • SSKN N/A
  • Industry
  • CARM Biotechnology: Pharmaceutical Preparations
  • SSKN Medical/Dental Instruments
  • Sector
  • CARM Health Care
  • SSKN Health Care
  • Exchange
  • CARM Nasdaq
  • SSKN Nasdaq
  • Market Cap
  • CARM 8.4M
  • SSKN 9.7M
  • IPO Year
  • CARM N/A
  • SSKN 2005
  • Fundamental
  • Price
  • CARM $0.42
  • SSKN $2.25
  • Analyst Decision
  • CARM Hold
  • SSKN Strong Buy
  • Analyst Count
  • CARM 5
  • SSKN 1
  • Target Price
  • CARM $0.90
  • SSKN $6.00
  • AVG Volume (30 Days)
  • CARM 42.1M
  • SSKN 7.7K
  • Earning Date
  • CARM 08-07-2025
  • SSKN 08-13-2025
  • Dividend Yield
  • CARM N/A
  • SSKN N/A
  • EPS Growth
  • CARM N/A
  • SSKN N/A
  • EPS
  • CARM N/A
  • SSKN N/A
  • Revenue
  • CARM $19,964,000.00
  • SSKN $33,620,000.00
  • Revenue This Year
  • CARM N/A
  • SSKN $3.31
  • Revenue Next Year
  • CARM N/A
  • SSKN $9.67
  • P/E Ratio
  • CARM N/A
  • SSKN N/A
  • Revenue Growth
  • CARM 32.45
  • SSKN 3.30
  • 52 Week Low
  • CARM $0.14
  • SSKN $2.10
  • 52 Week High
  • CARM $1.90
  • SSKN $3.80
  • Technical
  • Relative Strength Index (RSI)
  • CARM 52.02
  • SSKN 41.73
  • Support Level
  • CARM $0.41
  • SSKN $2.20
  • Resistance Level
  • CARM $0.56
  • SSKN $2.43
  • Average True Range (ATR)
  • CARM 0.13
  • SSKN 0.10
  • MACD
  • CARM -0.01
  • SSKN 0.00
  • Stochastic Oscillator
  • CARM 20.33
  • SSKN 16.67

About CARM Carisma Therapeutics Inc.

CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. The company has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells.

About SSKN Strata Skin Sciences Inc.

Strata Skin Sciences Inc is a medical technology company engaged in developing and commercializing products for the treatment of dermatological disorders. Its primary products include the XTRAC excimer laser and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its operating segment includes Dermatology Recurring Procedures, which is the key revenue driver and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. Its Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. Geographically, it derives a majority of revenue from the United States.

Share on Social Networks: